Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease

Journal of Immunology

Volumn 184, Issue 8, 2010, Pages 4460-4469

  Motz, Gregory T ^a   Eppert, Bryan L ^a   Wortham, Brian W ^a   Amos Kroohs, Robyn M ^a   Flury, Jennifer L ^a   Wesselkamper, Scott C ^a   Borchers, Michael T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CIGARETTE SMOKE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; MEMBRANE PROTEIN; PROTEIN RAET1; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; AUTACOID; CPG ODN 1826; DNA; POLYINOSINIC POLYCYTIDYLIC ACID; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SMOKING CESSATION; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COCULTURE; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; PASSIVE SMOKING; PATHOLOGY; TRANSGENIC MOUSE; UPREGULATION; VIROLOGY;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DNA; FEMALE; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLY I-C; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, VIRAL; TOBACCO SMOKE POLLUTION; UP-REGULATION;

EID: 77952784713     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903654     Document Type: Article

References (58)

1. Rabe, K. F., S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, and J. Zielinski; Global Initiative for Chronic Obstructive Lung Disease. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176: 532-555.
2. Rennard, S. I., and J. Vestbo. 2006. COPD: the dangerous underestimate of 15%. Lancet 367: 1216-1219.
3. Pauwels, R. A., and K. F. Rabe. 2004. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620. (Pubitemid 39094180)
4. Cosio, M. G., M. Saetta, and A. Agusti. 2009. Immunologic aspects of chronic obstructive pulmonary disease. N. Engl. J. Med. 360: 2445-2454.
5. Hogg, J. C., F. Chu, S. Utokaparch, R. Woods, W. M. Elliott, L. Buzatu, R. M. Cherniack, R. M. Rogers, F. C. Sciurba, H. O. Coxson, and P. D. Paré. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350: 2645-2653.
6. Borchers, M. T., S. C. Wesselkamper, V. Curull, A. Ramirez-Sarmiento, A. Sánchez-Font, J. Garcia-Aymerich, C. Coronell, J. Lloreta, A. G. Agusti, J. Gea, et al. 2009. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J. Clin. Invest. 119: 636-649.
7. Motz, G. T., B. L. Eppert, G. Sun, S. C. Wesselkamper, M. J. Linke, R. Deka, and M. T. Borchers. 2008. Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema. J. Immunol. 181: 8036-8043.
8. Borchers, M. T., S. C. Wesselkamper, N. L. Harris, H. Deshmukh, E. Beckman, M. Vitucci, J. W. Tichelaar, and G. D. Leikauf. 2007. CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure. Exp. Mol. Pathol. 83: 301-310.
9. Sapey, E., and R. A. Stockley. 2006. COPD exacerbations. 2: aetiology. Thorax 61: 250-258.
10. Bhowmik, A., T. A. R. Seemungal, R. J. Sapsford, and J. A. Wedzicha. 2000. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 55: 114-120. (Pubitemid 30245950)
11. Quint, J. K., R. Baghai-Ravary, G. C. Donaldson, and J. A. Wedzicha. 2008. Relationship between depression and exacerbations in COPD. Eur. Respir. J. 32: 53-60.
12. Groenewegen, K. H., A. M. W. J. Schols, and E. F. M. Wouters. 2003. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124: 459-467.
13. Connors, A. F., Jr., N. V. Dawson, C. Thomas, F. E. Harrell, Jr., N. Desbiens, W. J. Fulkerson, P. Kussin, P. Bellamy, L. Goldman, and W. A. Knaus. 1996. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am. J. Respir. Crit. Care Med. 154: 959-967.
14. Celli, B. R., and P. J. Barnes. 2007. Exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 29: 1224-1238.
15. Wedzicha, J. A. 2004. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1: 115-120.
16. Kang, M. J., C. G. Lee, J. Y. Lee, C. S. Dela Cruz, Z. J. Chen, R. Enelow, and J. A. Elias. 2008. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J. Clin. Invest. 118: 2771-2784.
17. Newman, K. C., and E. M. Riley. 2007. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7: 279-291.
18. Kawai, T., and S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7: 131-137.
19. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517. (Pubitemid 46602996)
20. Strowig, T., F. Brilot, and C. Münz. 2008. Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J. Immunol. 180: 7785-7791.
21. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
22. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189.
23. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182: 1045-1056.
24. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178: 567-577.
25. Wesselkamper, S. C., B. L. Eppert, G. T. Motz, G. W. Lau, D. J. Hassett, and M. T. Borchers. 2008. NKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection. J. Immunol. 181: 5481-5489.
26. + T cells provide an early source of IFN-gamma. J. Immunol. 170: 2399-2408.
27. Gaschler, G. J., C. C. Zavitz, C. M. Bauer, M. Skrtic, M. Lindahl, C. S. Robbins, B. Chen, and M. R. Stämpfli. 2008. Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 38: 218-226.
28. Chen, H., M. J. Cowan, J. D. Hasday, S. N. Vogel, and A. E. Medvedev. 2007. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J. Immunol. 179: 6097-6106.
29. Kroening, P. R., T. W. Barnes, L. Pease, A. Limper, H. Kita, and R. Vassallo. 2008. Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. J. Immunol. 181: 1536-1547.
30. Gaschler, G. J., M. Skrtic, C. C. Zavitz, M. Lindahl, P. O. Onnervik, T. F. Murphy, S. Sethi, and M. R. Stämpfli. 2009. Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. Am. J. Respir. Crit. Care Med. 179: 666-675.
31. Sethi, S., N. Evans, B. J. Grant, and T. F. Murphy. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347: 465-471.
32. Au, D. H., C. L. Bryson, J. W. Chien, H. Sun, E. M. Udris, L. E. Evans, and K. A. Bradley. 2009. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J. Gen. Intern. Med. 24: 457-463.
33. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am. J. Respir. Crit. Care Med. 164: 358-364.
34. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22. (Pubitemid 39626587)
35. D'hulst, A. I., T. Maes, K. R. Bracke, I. K. Demedts, K. G. Tournoy, G. F. Joos, and G. G. Brusselle. 2005. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? Respir. Res. 6: 147.
36. Botelho, F. M., G. J. Gaschler, S. Kianpour, C. C. J. Zavitz, N. J. Trimble, J. K. Nikota, C. M. T. Bauer, and M. R. Stampfli. 2009. Innate immune processes are sufficient for driving cigarette smoke induced inflammation in mice. Am. J. Respir. Cell Mol. Biol. doi:10.1165/rcmb.2008-0301OC.
37. Wang, Z., T. Zheng, Z. Zhu, R. J. Homer, R. J. Riese, H. A. Chapman, Jr., S. D. Shapiro, and J. A. Elias. 2000. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192: 1587-1600.
38. Demedts, I. K., T. Demoor, K. R. Bracke, G. F. Joos, and G. G. Brusselle. 2006. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir. Res. 7: 53.
39. Majo, J., H. Ghezzo, and M. G. Cosio. 2001. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J. 17: 946-953.
40. Kasahara, Y., R. M. Tuder, C. D. Cool, D. A. Lynch, S. C. Flores, and N. F. Voelkel. 2001. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 163: 737-744.
41. Petrache, I., V. Natarajan, L. Zhen, T. R. Medler, A. T. Richter, C. Cho, W. C. Hubbard, E. V. Berdyshev, and R. M. Tuder. 2005. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat. Med. 11: 491-498.
42. Cosio, M. G. 2004. Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease. Eur. Respir. J. 24: 3-5.
43. Lee, S. H., S. Goswami, A. Grudo, L. Z. Song, V. Bandi, S. Goodnight-White, L. Green, J. Hacken-Bitar, J. Huh, F. Bakaeen, et al. 2007. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat. Med. 13: 567-569.
44. Feghali-Bostwick, C. A., A. S. Gadgil, L. E. Otterbein, J. M. Pilewski, M. W. Stoner, E. Csizmadia, Y. Zhang, F. C. Sciurba, and S. R. Duncan. 2008. Autoantibodies in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177: 156-163.
45. Shi, F. D., and L. Van Kaer. 2006. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat. Rev. Immunol. 6: 751-760.
46. Kono, H., and K. L. Rock. 2008. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8: 279-289.
47. Chaix, J., M. S. Tessmer, K. Hoebe, N. Fuséri, B. Ryffel, M. Dalod, L. Alexopoulou, B. Beutler, L. Brossay, E. Vivier, and T. Walzer. 2008. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181: 1627-1631.
48. Tsoumakidou, M., I. K. Demedts, G. G. Brusselle, and P. K. Jeffery. 2008. Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. Am. J. Respir. Crit. Care Med. 177: 1180-1186.
49. Freeman, C. M., F. J. Martinez, M. K. Han, T. M. Ames, S. W. Chensue, J. C. Todt, D. A. Arenberg, C. A. Meldrum, C. Getty, L. McCloskey, and J. L. Curtis. 2009. Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 180: 1179-1188.
50. D'hulst, A. I., K. Y. Vermaelen, G. G. Brusselle, G. F. Joos, and R. A. Pauwels. 2005. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur. Respir. J. 26: 204-213.
51. Mortaz, E., A. D. Kraneveld, J. J. Smit, M. Kool, B. N. Lambrecht, S. L. Kunkel, N. W. Lukacs, F. P. Nijkamp, and G. Folkerts. 2009. Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PLoS One 4: e4946.
52. Cooper, M. A., J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero, and W. M. Yokoyama. 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 106: 1915-1919.
53. Girart, M. V., M. B. Fuertes, C. I. Domaica, L. E. Rossi, and N. W. Zwirner. 2007. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J. Immunol. 179: 3472-3479.
54. Hart, O. M., V. Athie-Morales, G. M. O'Connor, and C. M. Gardiner. 2005. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J. Immunol. 175: 1636-1642.
55. Mian, M. F., N. M. Lauzon, M. R. Stämpfli, K. L. Mossman, and A. A. Ashkar. 2008. Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. J. Leukoc. Biol. 83: 774-784.
56. Urbanowicz, R. A., J. R. Lamb, I. Todd, J. M. Corne, and L. C. Fairclough. 2009. Altered effector function of peripheral cytotoxic cells in COPD. Respir. Res. 10: 53.
57. Zhu, X., A. S. Gadgil, R. Givelber, M. P. George, M. W. Stoner, F. C. Sciurba, and S. R. Duncan. 2009. Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease. J. Immunol. 182: 3270-3277.
58. Lu, L.-M., C. C. J. Zavitz, B. Chen, S. Kianpour, Y. Wan, and M. R. Stämpfli. 2007. Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J. Immunol. 178: 936-943.